Synsam AB (publ) (SYNSAM.ST)
SEK 42.3
(0.83%)
SEK 42.3
(0.83%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.67 Billion SEK | -9.48% |
| 2022 | 2.95 Billion SEK | 24.55% |
| 2021 | 2.37 Billion SEK | -62.02% |
| 2020 | 6.24 Billion SEK | -5.06% |
| 2019 | 6.57 Billion SEK | 9.15% |
| 2018 | 6.02 Billion SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 2.78 Billion SEK | 1.27% |
| 2024 Q1 | 2.75 Billion SEK | 2.99% |
| 2023 Q4 | 2.67 Billion SEK | -9.02% |
| 2023 Q2 | 2.96 Billion SEK | 1.99% |
| 2023 Q1 | 2.91 Billion SEK | -1.42% |
| 2023 Q3 | 2.93 Billion SEK | -1.04% |
| 2023 FY | 2.67 Billion SEK | -9.48% |
| 2022 Q4 | 2.95 Billion SEK | 3.61% |
| 2022 FY | 2.95 Billion SEK | 24.55% |
| 2022 Q3 | 2.85 Billion SEK | -2.2% |
| 2022 Q2 | 2.91 Billion SEK | 11.31% |
| 2022 Q1 | 2.61 Billion SEK | 10.42% |
| 2021 Q1 | 6.55 Billion SEK | 8.89% |
| 2021 Q4 | 2.37 Billion SEK | -63.46% |
| 2021 Q3 | 6.48 Billion SEK | 1.36% |
| 2021 Q2 | 6.4 Billion SEK | -2.33% |
| 2021 FY | 2.37 Billion SEK | -62.02% |
| 2020 FY | 6.24 Billion SEK | -5.06% |
| 2020 Q4 | 6.02 Billion SEK | 0.0% |
| 2020 Q1 | 222.9 Million SEK | 0.0% |
| 2019 FY | 6.57 Billion SEK | 9.15% |
| 2018 FY | 6.02 Billion SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.01 Billion SEK | 46.721% |
| Biotage AB (publ) | -444 Million SEK | 702.027% |
| Bonesupport Holding AB (publ) | -149.86 Million SEK | 1883.581% |
| Doxa AB (publ) | -102.2 Million SEK | 2715.46% |
| Elekta AB (publ) | 4.46 Billion SEK | 40.188% |
| iZafe Group AB (publ) | -2.65 Million SEK | 100626.514% |
| Ortivus AB (publ) | 4.19 Million SEK | -63664.313% |
| Ortivus AB (publ) | 4.19 Million SEK | -63664.313% |
| Q-linea AB (publ) | -61.33 Million SEK | 4458.389% |
| S2Medical AB (publ) | -1.51 Million SEK | 176299.78% |